Contributors |
|
xii | (2) |
Preface |
|
xiv | |
|
1 History-taking and physical examination |
|
|
1 | (31) |
|
1.1 General instructional objective |
|
|
1 | (11) |
|
1.2 Specific behavioural objectives |
|
|
1 | (11) |
|
1.3 Reasons for learning to take a relevant history and performing a specific obstetric and gynaecological examination |
|
|
1 | (2) |
|
|
3 | (2) |
|
1.5 History of the present pregnancy |
|
|
5 | (1) |
|
1.6 Obstetric examination |
|
|
5 | (13) |
|
1.7 Vaginal examination in gynaecology |
|
|
18 | (13) |
|
|
31 | (1) |
|
2 Adverse factors affecting embryo or fetus |
|
|
32 | (19) |
|
2.1 General instructional objective |
|
|
32 | (1) |
|
2.2 Specific behavioural objectives |
|
|
32 | (1) |
|
2.3 Reasons for learning to appreciate the pre-conceptual, antenatal and intrapartum factors that may adversely affect an embryo or fetus in utero |
|
|
33 | (1) |
|
2.4 Genetic and social factors |
|
|
34 | (4) |
|
2.5 Retarded intrauterine growth of the fetus |
|
|
38 | (4) |
|
2.6 Small-for-gestational-age babies |
|
|
42 | (1) |
|
2.7 Management of growth retardation |
|
|
43 | (1) |
|
|
44 | (1) |
|
|
45 | (4) |
|
|
49 | (1) |
|
|
50 | (1) |
|
3 Drug treatment in pregnancy |
|
|
51 | (12) |
|
3.1 General instructional objective |
|
|
51 | (1) |
|
3.2 Specific behavioural objectives |
|
|
51 | (1) |
|
3.3 Reasons for learning about drug treatment in pregnancy |
|
|
51 | (1) |
|
|
52 | (1) |
|
3.5 Drug use in pregnancy |
|
|
52 | (6) |
|
3.6 Drug use in obstetrics |
|
|
58 | (2) |
|
3.7 Drug use in lactation |
|
|
60 | (2) |
|
|
62 | (1) |
|
|
63 | (24) |
|
4.1 General instructional objective |
|
|
63 | (1) |
|
4.2 Specific behavioural objectives |
|
|
63 | (1) |
|
4.3 Reasons for understanding the normal pregnancy |
|
|
64 | (1) |
|
4.4 Physiological changes in the mother |
|
|
65 | (4) |
|
|
69 | (2) |
|
4.6 Symptoms and signs detected during pregnancy |
|
|
71 | (5) |
|
4.7 The first antenatal visit |
|
|
76 | (2) |
|
|
78 | (1) |
|
|
79 | (1) |
|
4.10 Estimation of the date of confinement |
|
|
79 | (1) |
|
4.11 Investigations performed during pregnancy |
|
|
80 | (2) |
|
|
82 | (5) |
|
5 Deviations from normal pregnancy |
|
|
87 | (55) |
|
5.1 General instructional objective |
|
|
87 | (1) |
|
5.2 Specific behavioural objectives |
|
|
87 | (1) |
|
5.3 Reasons for studying deviations from normal pregnancy |
|
|
88 | (1) |
|
5.4 Bleeding in late pregnancy |
|
|
89 | (6) |
|
5.5 Renal diseases associated with pregnancy |
|
|
95 | (5) |
|
|
100 | (3) |
|
5.7 Heart disease in pregnancy |
|
|
103 | (3) |
|
|
106 | (2) |
|
5.9 Counselling in relation to an abnormal pregnancy |
|
|
108 | (1) |
|
5.10 Convulsions in pregnancy and the puerperium |
|
|
109 | (2) |
|
|
111 | (1) |
|
5.12 Rhesus iso-immunization and haemolytic disease |
|
|
112 | (4) |
|
5.13 Glycosuria and diabetes mellitus |
|
|
116 | (4) |
|
5.14 Amniocentesis in pregnancy |
|
|
120 | (3) |
|
5.15 Radiology in pregnancy |
|
|
123 | (1) |
|
5.16 Ultrasound in pregnancy |
|
|
124 | (1) |
|
5.17 Radioisotopes in pregnancy |
|
|
125 | (1) |
|
5.18 Investigation of suspected fetal growth retardation |
|
|
126 | (2) |
|
5.19 Pre-eclampsia and eclampsia |
|
|
128 | (7) |
|
5.20 Intrauterine fetal death |
|
|
135 | (1) |
|
5.21 Coagulation defects in obstetrics |
|
|
136 | (1) |
|
|
137 | (5) |
|
6 Normal labour and delivery |
|
|
142 | (38) |
|
6.1 General instructional objective |
|
|
142 | (1) |
|
6.2 Specific behavioural objectives |
|
|
142 | (1) |
|
6.3 Reasons for understanding normal labour and delivery, and resuscitation of the newborn |
|
|
143 | (1) |
|
6.4 Anatomy of the female pelvis |
|
|
143 | (6) |
|
|
149 | (5) |
|
6.6 Physiological process in labour (the powers) |
|
|
154 | (2) |
|
|
156 | (5) |
|
|
161 | (14) |
|
|
175 | (5) |
|
|
180 | (25) |
|
7.1 General instructional objective |
|
|
180 | (1) |
|
7.2 Specific behavioural objectives |
|
|
180 | (1) |
|
7.3 Examination of the newborn |
|
|
180 | (6) |
|
|
186 | (1) |
|
|
187 | (2) |
|
7.6 Small-for-dates infants |
|
|
189 | (1) |
|
7.7 Large-for-dates infants |
|
|
190 | (1) |
|
7.8 Infant of the diabetic mother |
|
|
190 | (1) |
|
7.9 Hypoglycaemia in the newborn |
|
|
191 | (2) |
|
7.10 Jaundice in the newborn |
|
|
193 | (4) |
|
7.11 Infections in the newborn |
|
|
197 | (1) |
|
7.12 Respiratory problems of the newborn |
|
|
198 | (5) |
|
7.13 Neonatal convulsions |
|
|
203 | (2) |
|
|
205 | (31) |
|
8.1 General instructional objective |
|
|
205 | (1) |
|
8.2 Specific behavioural objectives |
|
|
205 | (1) |
|
8.3 Reasons for studying abnormal labour |
|
|
206 | (1) |
|
|
206 | (4) |
|
8.5 Types of abnormal uterine activity |
|
|
210 | (4) |
|
|
214 | (2) |
|
|
216 | (5) |
|
8.8 Transverse and oblique lie |
|
|
221 | (2) |
|
|
223 | (2) |
|
|
225 | (2) |
|
8.11 Twin pregnancy and unsuspected second twin |
|
|
227 | (1) |
|
8.12 Indications for Caesarean section |
|
|
227 | (1) |
|
8.13 Vaginal birth after Caesarean section (VBAC) |
|
|
228 | (1) |
|
8.14 Application of obstetric forceps |
|
|
229 | (1) |
|
8.15 Postpartum haemorrhage |
|
|
230 | (2) |
|
8.16 Intrapartum haemorrhage |
|
|
232 | (1) |
|
|
232 | (1) |
|
|
233 | (3) |
|
9 Analgesia and anaesthetics in obstetrics |
|
|
236 | (18) |
|
9.1 General instructional objective |
|
|
236 | (1) |
|
9.2 Specific behavioural objectives |
|
|
236 | (1) |
|
9.3 The pain of parturition |
|
|
237 | (2) |
|
9.4 Pain relief in labour |
|
|
239 | (11) |
|
9.5 General anaesthesia for obstetrics |
|
|
250 | (2) |
|
|
252 | (2) |
|
|
254 | (32) |
|
10.1 General instructional objective |
|
|
254 | (1) |
|
10.2 Specific behavioural objectives |
|
|
254 | (1) |
|
10.3 Reasons for learning about the puerperium |
|
|
254 | (1) |
|
10.4 Normal anatomical and physiological changes during the puerperium |
|
|
255 | (5) |
|
10.5 Management of the puerperium |
|
|
260 | (8) |
|
|
268 | (11) |
|
10.7 Thrombosis and embolism |
|
|
279 | (4) |
|
10.8 Secondary postpartum haemorrhage |
|
|
283 | (1) |
|
|
283 | (1) |
|
|
284 | (2) |
|
11 Abortion, ectopic pregnancy and trophoblastic diseases |
|
|
286 | (19) |
|
11.1 General instructional objective |
|
|
286 | (1) |
|
11.2 Specific behavioural objectives |
|
|
286 | (1) |
|
11.3 Reasons for learning about abortions |
|
|
287 | (1) |
|
11.4 Abortion (miscarriage) |
|
|
287 | (12) |
|
|
299 | (4) |
|
11.6 Hydatidiform mole and choriocarcinoma |
|
|
303 | (2) |
|
12 Contraception and infertility |
|
|
305 | (31) |
|
12.1 General instructional objective |
|
|
305 | (1) |
|
12.2 Specific behavioural objectives |
|
|
305 | (1) |
|
12.3 Reasons for learning about contraception and infertility |
|
|
306 | (1) |
|
|
306 | (3) |
|
12.5 Safety of oral contraception |
|
|
309 | (1) |
|
12.6 Mode of action of oral contraceptives |
|
|
309 | (2) |
|
12.7 Side effects of oral contraceptives |
|
|
311 | (4) |
|
12.8 Other forms of contraception |
|
|
315 | (4) |
|
12.9 Infertility and subfertility |
|
|
319 | (17) |
|
13 Genital tract infections and discharge |
|
|
336 | (25) |
|
13.1 General instructional objective |
|
|
336 | (1) |
|
13.2 Specific behavioural objectives |
|
|
336 | (1) |
|
13.3 Reasons for learning about genital tract infection |
|
|
336 | (1) |
|
13.4 Achievement of specific behaviours |
|
|
337 | (1) |
|
|
337 | (12) |
|
|
349 | (1) |
|
13.7 Human immunodeficiency virus infection |
|
|
350 | (1) |
|
|
351 | (10) |
|
14 Gynaecological endocrinology |
|
|
361 | (22) |
|
14.1 General instructional objective |
|
|
361 | (1) |
|
14.2 Specific behavioural objectives |
|
|
361 | (1) |
|
14.3 Reasons for learning about gynaecological endocrinology |
|
|
361 | (1) |
|
14.4 The hormonal control of the normal menstrual cycle |
|
|
362 | (5) |
|
14.5 Abnormal uterine bleeding |
|
|
367 | (5) |
|
|
372 | (2) |
|
14.7 Premenstrual syndrome (PMS) |
|
|
374 | (2) |
|
14.8 Amenorrhoea and anovulation |
|
|
376 | (3) |
|
|
379 | (1) |
|
14.10 Androgen excess - polycystic ovary syndrome (PCO) |
|
|
380 | (3) |
|
|
383 | (8) |
|
15.1 General instructional objective |
|
|
383 | (1) |
|
15.2 Specific behavioural objectives |
|
|
383 | (1) |
|
15.3 Reasons for learning about the menopause |
|
|
383 | (1) |
|
15.4 Physiological activity of sex steroids |
|
|
384 | (3) |
|
15.5 Pharmacological agents available for treatment |
|
|
387 | (1) |
|
|
388 | (3) |
|
16 Prolapse and urinary incontinence |
|
|
391 | (21) |
|
16.1 General instructional objective |
|
|
391 | (1) |
|
16.2 Specific behavioural objective |
|
|
391 | (1) |
|
16.3 Reasons for learning about prolapse and urinary incontinence |
|
|
392 | (1) |
|
|
392 | (1) |
|
16.5 Uterovaginal prolapse |
|
|
392 | (2) |
|
16.6 Anatomical considerations |
|
|
394 | (2) |
|
16.7 Causes of uterovaginal prolapse |
|
|
396 | (2) |
|
16.8 Symptoms and signs of prolapse |
|
|
398 | (2) |
|
16.9 Management of prolapse |
|
|
400 | (2) |
|
16.10 Urinary incontinence |
|
|
402 | (2) |
|
16.11 Symptoms and signs of urinary incontinence |
|
|
404 | (1) |
|
16.12 Urogynaecological assessment |
|
|
405 | (4) |
|
16.13 Management of urinary incontinence |
|
|
409 | (3) |
|
17 Benign and malignant tumours |
|
|
412 | (39) |
|
17.1 General instructional objective |
|
|
412 | (1) |
|
17.2 Specific behavioural objectives |
|
|
412 | (1) |
|
17.3 Reasons for learning about benign and malignant tumours of the female genital tract |
|
|
413 | (1) |
|
17.4 Types of tumours of the genital tract |
|
|
414 | (1) |
|
17.5 Physiological ovarian cysts |
|
|
414 | (2) |
|
17.6 Benign ovarian tumours |
|
|
416 | (1) |
|
|
417 | (4) |
|
|
421 | (3) |
|
|
424 | (1) |
|
|
425 | (3) |
|
17.11 Carcinoma of the endometrium |
|
|
428 | (4) |
|
17.12 Tumours of the cervix |
|
|
432 | (1) |
|
17.13 Carcinoma of the cervix |
|
|
433 | (11) |
|
|
444 | (2) |
|
|
446 | (5) |
|
|
451 | (16) |
|
18.1 General instructional objective |
|
|
451 | (1) |
|
18.2 Specific behavioural objectives |
|
|
451 | (1) |
|
18.3 Reasons for learning about human sexuality |
|
|
452 | (1) |
|
|
452 | (1) |
|
18.5 The sexual response cycle |
|
|
453 | (2) |
|
18.6 Factors affecting human sexuality |
|
|
455 | (2) |
|
|
457 | (2) |
|
18.8 Human sexual problems |
|
|
459 | (5) |
|
18.9 Sexuality in pregnancy |
|
|
464 | (3) |
Index |
|
467 | |